168 related articles for article (PubMed ID: 32664938)
1. Neurofibromatosis I and multiple sclerosis.
Bergqvist C; Hemery F; Ferkal S; Wolkenstein P
Orphanet J Rare Dis; 2020 Jul; 15(1):186. PubMed ID: 32664938
[TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferative malignancies in patients with neurofibromatosis 1.
Bergqvist C; Hemery F; Jannic A; Ferkal S; Wolkenstein P
Orphanet J Rare Dis; 2021 May; 16(1):230. PubMed ID: 34011343
[TBL] [Abstract][Full Text] [Related]
3. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
[TBL] [Abstract][Full Text] [Related]
4. Phenotype-Genotype Correlation in Children with Neurofibromatosis Type 1.
Barrea C; Vaessen S; Bulk S; Harvengt J; Misson JP
Neuropediatrics; 2018 Jun; 49(3):180-184. PubMed ID: 29471550
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease.
Abramowicz A; Gos M
Dev Period Med; 2014; 18(3):297-306. PubMed ID: 25182393
[TBL] [Abstract][Full Text] [Related]
6. Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1.
Ko JM; Sohn YB; Jeong SY; Kim HJ; Messiaen LM
Pediatr Neurol; 2013 Jun; 48(6):447-53. PubMed ID: 23668869
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS).
Ciotti S; Cometa A; De Carlo C; Martini G; Marona A; Filippetti L; Carducci D; Baratta S; Zampolini M; Corea F
Eur J Case Rep Intern Med; 2021; 8(3):002190. PubMed ID: 33768065
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.
Ferner RE; Huson SM; Thomas N; Moss C; Willshaw H; Evans DG; Upadhyaya M; Towers R; Gleeson M; Steiger C; Kirby A
J Med Genet; 2007 Feb; 44(2):81-8. PubMed ID: 17105749
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension in patients with neurofibromatosis type I.
Montani D; Coulet F; Girerd B; Eyries M; Bergot E; Mal H; Biondi G; Dromer C; Hugues T; Marquette C; O'Connell C; O'Callaghan DS; Savale L; Jaïs X; Dorfmüller P; Begueret H; Bertoletti L; Sitbon O; Bellanné-Chantelot C; Zalcman G; Simonneau G; Humbert M; Soubrier F
Medicine (Baltimore); 2011 May; 90(3):201-211. PubMed ID: 21512413
[TBL] [Abstract][Full Text] [Related]
11. [Molecular diagnosis as a strategy for differential diagnosis and at early ages of neurofibromatosis type 1 (NF1)].
Gómez M; Batista O
Rev Med Chil; 2015 Oct; 143(10):1320-30. PubMed ID: 26633276
[TBL] [Abstract][Full Text] [Related]
12. Primary progressive multiple sclerosis and neurofibromatosis type 1.
Iwanowski P; Kowalska M; Prendecki M; Dorszewska J; Kozubski W; Rydzanicz M; Płoski R; Losy J
Mult Scler Relat Disord; 2019 Jul; 32():66-69. PubMed ID: 31048186
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study.
Evans DGR; Kallionpää RA; Clementi M; Trevisson E; Mautner VF; Howell SJ; Lewis L; Zehou O; Peltonen S; Brunello A; Harkness EF; Wolkenstein P; Peltonen J
Genet Med; 2020 Feb; 22(2):398-406. PubMed ID: 31495828
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.
Anastasaki C; Woo AS; Messiaen LM; Gutmann DH
Hum Mol Genet; 2015 Jun; 24(12):3518-28. PubMed ID: 25788518
[TBL] [Abstract][Full Text] [Related]
15. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
[TBL] [Abstract][Full Text] [Related]
16. Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1.
Xiao H; Yuan L; Xu H; Yang Z; Huang F; Song Z; Yang Y; Zeng C; Deng H
J Mol Neurosci; 2018 Aug; 65(4):557-563. PubMed ID: 30046999
[TBL] [Abstract][Full Text] [Related]
17. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
Ratner N; Miller SJ
Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329
[TBL] [Abstract][Full Text] [Related]
18. Identification of a missense mutation causing exon skipping in a neurofibromatosis type 1 patient.
Fu Y; Zhang JQ; Jiang CL; Wang HY
J Dermatol; 2018 Aug; 45(8):986-988. PubMed ID: 29952103
[TBL] [Abstract][Full Text] [Related]
19. Co-occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2.
Peces R; Mena R; Martín Y; Hernández C; Peces C; Tellería D; Cuesta E; Selgas R; Lapunzina P; Nevado J
Mol Genet Genomic Med; 2020 Aug; 8(8):e1321. PubMed ID: 32533764
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis type 1 and infantile spasms.
Ruggieri M; Iannetti P; Clementi M; Polizzi A; Incorpora G; Spalice A; Pavone P; Praticò AD; Elia M; Gabriele AL; Tenconi R; Pavone L
Childs Nerv Syst; 2009 Feb; 25(2):211-6. PubMed ID: 18802710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
